305 related articles for article (PubMed ID: 8876777)
21. PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PET.
Gonzalez-Escamilla G; Lange C; Teipel S; Buchert R; Grothe MJ;
Neuroimage; 2017 Feb; 147():669-677. PubMed ID: 28039094
[TBL] [Abstract][Full Text] [Related]
22. Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease.
Teipel SJ; Hampel H; Pietrini P; Alexander GE; Horwitz B; Daley E; Möller HJ; Schapiro MB; Rapoport SI
Arch Neurol; 1999 Apr; 56(4):467-73. PubMed ID: 10199337
[TBL] [Abstract][Full Text] [Related]
23. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
[TBL] [Abstract][Full Text] [Related]
24. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
[TBL] [Abstract][Full Text] [Related]
25. Mapping the relative contribution of gray matter activity vs. volume in brain PET: a new approach.
Berkouk K; Quarantelli M; Prinster A; Landeau B; Alfano B; Baron JC
J Neuroimaging; 2006 Jul; 16(3):224-35. PubMed ID: 16808824
[TBL] [Abstract][Full Text] [Related]
26. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
27. The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease.
Thomas BA; Erlandsson K; Modat M; Thurfjell L; Vandenberghe R; Ourselin S; Hutton BF
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1104-19. PubMed ID: 21336694
[TBL] [Abstract][Full Text] [Related]
28. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
[TBL] [Abstract][Full Text] [Related]
29. Resting state brain glucose metabolism is not reduced in normotensive healthy men during aging, after correction for brain atrophy.
Ibáñez V; Pietrini P; Furey ML; Alexander GE; Millet P; Bokde AL; Teichberg D; Schapiro MB; Horwitz B; Rapoport SI
Brain Res Bull; 2004 Mar; 63(2):147-54. PubMed ID: 15130704
[TBL] [Abstract][Full Text] [Related]
30. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
[TBL] [Abstract][Full Text] [Related]
31. The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.
Prestia A; Baglieri A; Pievani M; Bonetti M; Rasser PE; Thompson PM; Marino S; Bramanti P; Frisoni GB
Suppl Clin Neurophysiol; 2013; 62():67-80. PubMed ID: 24053032
[TBL] [Abstract][Full Text] [Related]
32. Regional changes of cortical mean diffusivities with aging after correction of partial volume effects.
Jeon T; Mishra V; Uh J; Weiner M; Hatanpaa KJ; White CL; Zhao YD; Lu H; Diaz-Arrastia R; Huang H
Neuroimage; 2012 Sep; 62(3):1705-16. PubMed ID: 22683383
[TBL] [Abstract][Full Text] [Related]
33. Mean diffusivity in cortical gray matter in Alzheimer's disease: The importance of partial volume correction.
Henf J; Grothe MJ; Brueggen K; Teipel S; Dyrba M
Neuroimage Clin; 2018; 17():579-586. PubMed ID: 29201644
[TBL] [Abstract][Full Text] [Related]
34. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease.
Baron JC; Chételat G; Desgranges B; Perchey G; Landeau B; de la Sayette V; Eustache F
Neuroimage; 2001 Aug; 14(2):298-309. PubMed ID: 11467904
[TBL] [Abstract][Full Text] [Related]
35. MRI-based correction for partial-volume effect improves detectability of intractable epileptogenic foci on 123I-iomazenil brain SPECT images.
Kato H; Shimosegawa E; Oku N; Kitagawa K; Kishima H; Saitoh Y; Kato A; Yoshimine T; Hatazawa J
J Nucl Med; 2008 Mar; 49(3):383-9. PubMed ID: 18287271
[TBL] [Abstract][Full Text] [Related]
36. Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography.
Ribeiro MJ; Almeida P; Strul D; Ferreira N; Loc'h C; Brulon V; Trébossen R; Mazière B; Bendriem B
Eur J Nucl Med; 1999 Jul; 26(7):758-66. PubMed ID: 10398824
[TBL] [Abstract][Full Text] [Related]
37. Selective metabolic reduction in gray matter acutely following human traumatic brain injury.
Wu HM; Huang SC; Hattori N; Glenn TC; Vespa PM; Yu CL; Hovda DA; Phelps ME; Bergsneider M
J Neurotrauma; 2004 Feb; 21(2):149-61. PubMed ID: 15000756
[TBL] [Abstract][Full Text] [Related]
38. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
39. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.
Chételat G; Desgranges B; Landeau B; Mézenge F; Poline JB; de la Sayette V; Viader F; Eustache F; Baron JC
Brain; 2008 Jan; 131(Pt 1):60-71. PubMed ID: 18063588
[TBL] [Abstract][Full Text] [Related]
40. [Quantitative estimation of brain atrophy and function with PET and MRI two-dimensional projection images].
Saito R; Toyama H; Uemura K; Ishii K; Senda M; Uchiyama A
Kaku Igaku; 2001 May; 38(3):201-9. PubMed ID: 11452485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
